)

HOOKIPA Pharma (HOOK) investor relations material
HOOKIPA Pharma Q1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Report covers Q1 2025, highlighting a strategic refocus, major restructuring, and a pause in key clinical programs, with continued partnership development, especially with Gilead for HBV and HIV therapies.
Workforce reduced by ~80% and Vienna operations consolidated to cut costs; eseba-vec clinical program paused, and Roche collaboration terminated.
Discussions for a potential acquisition of Poolbeg Pharma were terminated in February 2025.
Company remains pre-revenue from product sales, relying on collaboration, milestone, and grant income.
Financial highlights
Revenue was $2.0M in Q1 2025, down from $36.6M in Q1 2024, due to the end of the Roche collaboration and lower milestone recognition.
Net loss was $15.4M in Q1 2025, compared to net income of $14.4M in Q1 2024, reflecting lower revenue and ongoing expenses.
Research and development expenses decreased to $12.9M from $20.2M year-over-year, mainly due to program pauses and workforce reductions.
General and administrative expenses increased to $6.9M from $4.1M, driven by higher professional and consulting fees related to strategic reviews.
Cash, cash equivalents, and restricted cash totaled $40.5M as of March 31, 2025.
Outlook and guidance
Substantial doubt exists about the company's ability to continue as a going concern for at least 12 months without additional funding.
Management plans to seek further capital, reduce spending, and pursue strategic alternatives, but the probability of success is less than probable.
No expectation of positive cash flows from operations in the foreseeable future; further cost-saving initiatives may be implemented.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage